The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 638 | 3,680 | SH | SOLE | 3,680 | 0 | 0 | ||
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 764 | 6,717 | SH | SOLE | 6,717 | 0 | 0 | ||
| CYNOSURE INC | CL A | 232577205 | 1,341 | 43,729 | SH | SOLE | 43,729 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,018 | 16,332 | SH | SOLE | 16,332 | 0 | 0 | ||
| HUMANA INC | COM | 444859102 | 1,140 | 6,403 | SH | SOLE | 6,403 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 710 | 7,742 | SH | SOLE | 7,742 | 0 | 0 | ||
| LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 723 | 5,735 | SH | SOLE | 5,735 | 0 | 0 | ||
| LILLY ELI & CO | COM | 532457108 | 1,031 | 14,192 | SH | SOLE | 14,192 | 0 | 0 | ||
| MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 1,082 | 8,540 | SH | SOLE | 8,540 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 974 | 34,744 | SH | SOLE | 34,744 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,080 | 2,392 | SH | SOLE | 2,392 | 0 | 0 | ||
| THORATEC CORP | COM NEW | 885175307 | 1,037 | 24,765 | SH | SOLE | 24,765 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 1,864 | 10,808 | SH | SOLE | 10,808 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 1,819 | 15,453 | SH | SOLE | 15,453 | 0 | 0 | ||
| ZOETIS INC | CL A | 98978V103 | 683 | 14,747 | SH | SOLE | 14,747 | 0 | 0 | ||